Chemoinformaics analysis of 2-Isopropenylnaphtho[2,3-b]furan-4,9-dione
| Molecular Weight | 238.242 | nRot | 1 |
| Heavy Atom Molecular Weight | 228.162 | nRig | 18 |
| Exact Molecular Weight | 238.063 | nRing | 3 |
| Solubility: LogS | -5.73 | nHRing | 1 |
| Solubility: LogP | 4.016 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 11 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 11 |
| nHA | 3 | APOL | 34.1239 |
| nHD | 0 | BPOL | 13.5041 |
| QED | 0.654 |
| Synth | 2.61 |
| Natural Product Likeliness | 1.331 |
| NR-PPAR-gamma | 0.024 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.998 |
| Pgp-sub | 0 |
| HIA | 0.007 |
| CACO-2 | -4.677 |
| MDCK | 0.0000116 |
| BBB | 0.027 |
| PPB | 0.922621 |
| VDSS | 0.97 |
| FU | 0.0344694 |
| CYP1A2-inh | 0.966 |
| CYP1A2-sub | 0.25 |
| CYP2c19-inh | 0.666 |
| CYP2c19-sub | 0.069 |
| CYP2c9-inh | 0.523 |
| CYP2c9-sub | 0.322 |
| CYP2d6-inh | 0.031 |
| CYP2d6-sub | 0.128 |
| CYP3a4-inh | 0.214 |
| CYP3a4-sub | 0.149 |
| CL | 3.121 |
| T12 | 0.072 |
| hERG | 0.017 |
| Ames | 0.845 |
| ROA | 0.26 |
| SkinSen | 0.062 |
| Carcinogencity | 0.939 |
| EI | 0.852 |
| Respiratory | 0.122 |
| NR-Aromatase | 0.818 |
| Antiviral | Yes |
| Prediction | 0.688044 |